51 related articles for article (PubMed ID: 10632648)
21. Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group.
Cestari R
Aliment Pharmacol Ther; 1998 Oct; 12(10):991-6. PubMed ID: 9798804
[TBL] [Abstract][Full Text] [Related]
22. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
23. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G
Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Gisbert JP; Gonzalez L; Calvet X
Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
[TBL] [Abstract][Full Text] [Related]
25. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
Aliment Pharmacol Ther; 2000 Aug; 14(8):991-9. PubMed ID: 10930892
[TBL] [Abstract][Full Text] [Related]
26. Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.
Dixon JS; Pipkin GA; Mills JG; Wood JR
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():47-58. PubMed ID: 9440055
[TBL] [Abstract][Full Text] [Related]
27. Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection.
Chey WD; Fisher L; Barnett J; Delvalle J; Elta GH; Hasler WL; Nostrant T; Palaniappan J; Scheiman J
Aliment Pharmacol Ther; 1998 Dec; 12(12):1263-7. PubMed ID: 9882036
[TBL] [Abstract][Full Text] [Related]
28. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.
Pipkin GA; Williamson R; Wood JR
Aliment Pharmacol Ther; 1998 Sep; 12(9):823-37. PubMed ID: 9768524
[TBL] [Abstract][Full Text] [Related]
29. Dual and triple therapy regimens of antisecretory agents and antibiotics for the eradication of Helicobacter pylori: an overview.
Ciociola AA; Webb DD; Turner K
Scand J Gastroenterol Suppl; 1996; 218():3-9. PubMed ID: 8865444
[TBL] [Abstract][Full Text] [Related]
30. New options in Helicobacter pylori eradication: efficacy, resistance and synergy.
Williamson R; Pipkin GA; Wood JR
Scand J Gastroenterol Suppl; 1998; 225():36-40. PubMed ID: 9515751
[TBL] [Abstract][Full Text] [Related]
31. The treatment of Helicobacter pylori infection.
Pounder RE; Williams MP
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():35-41. PubMed ID: 9146789
[TBL] [Abstract][Full Text] [Related]
32. Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts.
Parente F; Cucino C; Bianchi Porro G
Dig Liver Dis; 2003 Aug; 35(8):523-8. PubMed ID: 14567454
[TBL] [Abstract][Full Text] [Related]
33. Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
Gisbert JP; Pajares JM
Aliment Pharmacol Ther; 2002 Jun; 16(6):1047-57. PubMed ID: 12030945
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori infection--current treatment practice.
Xia HH; Yu Wong BC; Talley NJ; Lam SK
Expert Opin Pharmacother; 2001 Feb; 2(2):253-66. PubMed ID: 11336584
[TBL] [Abstract][Full Text] [Related]
35. Where are We with current therapy?
Sung JJ
Helicobacter; 2000; 5 Suppl 1():S17-21; discussion S27-31. PubMed ID: 10828750
[TBL] [Abstract][Full Text] [Related]
36. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment.
Malfertheiner P
Scand J Gastroenterol Suppl; 1993; 196():34-7. PubMed ID: 8341989
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of Helicobacter pylori infections].
Hentschel E
Acta Med Austriaca; 2000; 27(4):104-7. PubMed ID: 10989677
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori: the challenge in therapy.
Bazzoli F; Pozzato P; Rokkas T
Helicobacter; 2002; 7 Suppl 1():43-9. PubMed ID: 12197909
[TBL] [Abstract][Full Text] [Related]
39. The actions of bismuth in the treatment of Helicobacter pylori infection.
Lambert JR; Midolo P
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():27-33. PubMed ID: 9146788
[TBL] [Abstract][Full Text] [Related]
40. Therapy for H. pylori infection.
Thomson AB
Curr Gastroenterol Rep; 1999 Dec; 1(6):518-23. PubMed ID: 10980996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
